PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors

Por Payne, S N, Maher, M E, Tran, N H, Van De Hey, D R, Foley, T M, Yueh, A E, Leystra, A A, Pasch, C A, Jeffrey, J J, Clipson, L, Matkowskyj, K A, Deming, D A
Publicado no Oncogenesis (2015)